• Bausch Health Acquires Eton’s M-100 Investigational Eye Drop americanpharmaceuticalreview
    February 20, 2019
    Bausch Health Companies and Bausch + Lomb, its wholly owned subsidiary and a leading global eye health company, and Eton Pharmaceuticals announced a subsidiary of Bausch Health has acquired the U.S. rights to Eton Pharmaceuticals' EM-100.....
PharmaSources Customer Service